Business Wire

Advantage Smollan Announces the Acquisition of Hamilton Bright

3.7.2017 15:00 | Business Wire

Del

Advantage Smollan, the joint holding company between Advantage Solutions (Advantage) and Global Smollan Holdings (Smollan), announced today its pending acquisition of Hamilton Bright Group B.V., a specialist in sales, brand activation and market intelligence in the Netherlands and Belgium. The completion of the acquisition is subject to customary closing conditions.

Advantage Smollan provides outsourced sales, marketing, and technology solutions for consumer goods manufacturers and retailers in a number of European markets. Hamilton Bright extends Advantage Smollan’s reach into the key markets of the Netherlands and Belgium and provide a unified solution for customers in these countries. Hamilton Bright will continue to operate under its current name.

Laurence Clube, Chief Operating Officer of Advantage Smollan, commented, “I am very excited about Hamilton Bright joining Advantage Smollan. This move brings a high quality business into the group and will enable us to improve and broaden what we do for our customers by sharing best practices.”

“To build Advantage Smollan’s footprint across Europe, we are targeting companies that are number one in their markets and share our entrepreneurial culture and passion for adding value. We have clearly found that in Hamilton Bright,” said Tanya Domier, CEO of Advantage.

David Smollan, Chief Executive Officer of Smollan, added, "We are excited to partner with Hamilton Bright who are a great cultural fit for our group and bring great expertise through their diversified service offerings".

Hamilton Bright was founded in 2000 and holds a client portfolio that includes many of the largest companies operating in the Netherlands and Belgium, whether of national or international origin.

“Hamilton Bright has a strong history of success in improving retail sales in the consumer electronics, body and healthcare, and food sectors,” said Claudio Missaglia, CEO of Hamilton Bright. “We believe that as part of Advantage Smollan we will continue to deliver exceptional results for our clients and to increase the opportunities for our people.”

About Advantage Smollan

Founded in 2015, Advantage Smollan is a jointly-owned holding company of Advantage Solutions (Advantage) and Global Smollan Holdings (Smollan) that provides unified sales, marketing, and technology solutions for consumer goods manufacturers and retailers across Europe. Advantage Smollan offers the industry’s best capabilities and technology along with the local knowledge to address the unique dynamics of individual markets. The company combines Advantage’s and Smollan’s best practices and resources with the extensive experience and market leadership of each portfolio company – all aligned in service excellence, thought leadership, and entrepreneurial spirit to deliver better results for clients and customers. For more information, visit www.advantagesmollan.com. For more information on Advantage, visit www.advantagesolutions.net. For more information on Smollan, visit www.smollan.com.

About Hamilton Bright Group

Hamilton Bright is a shopper sales & marketing specialist, building and strengthening brands on the shop floor for some of the biggest brands in consumer electronics, the food industry, DIY, out of home and personal & healthcare. Hamilton Bright specializes in providing sales, brand activation and marketing intelligence solutions in the Netherlands and Belgium. For additional information, visit www.hamiltonbright.com

Contact information

Advantage Solutions
Will Minton, VP Corporate Marketing
Tel: 949 797 3105
Email: will.minton@advantagesolutions.net
or
Bryce Robinson, General Counsel
Tel: 949 794 2204 Email:
bryce.robinson@advantagesolutions.net
or
Hamilton Bright
Claudio Missaglia, CEO
Tel: +31(0)6 53 215 747
Email: c.missaglia@hamiltonbright.com
or
Global Smollan Holdings
Monique Yaffe, Chief Marketing Officer
Tel: +27 11 458 000
Email: monique.yaffe@smollan.com
or
Advantage Smollan
Laurence Clube, COO
Tel: +44 (0)118927 1010
Email: lclube@advantagesmollan.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

XILAM Successfully Completes €15m Bond Issue on Euro PP Market27.7.2017 17:42Pressemelding

Regulatory News: Xilam (Paris:XIL) today announced the completion of its Euro PP bond issue. The €15 million private placement, repayable at maturity, was subscribed by the NOVI 2 fund managed by Idinvest Partners on behalf of institutional investors and by a European insurer. The bonds have a 6-year maturity, and will be issued in two tranches: The first tranche will be at a variable rate of 6-month EURIBOR* + 400 bp The second tranche will be at a fixed rate of 3.5%. Favourable terms were obtained for the issue with successive drawdown options (limited to 18 months), which will allow the company to optimise the cost of its debt according to its needs. Xilam was advised on the transaction by Euroland Corporate. “We are delighted to have successfully completed this financing transacti

SFL – First-Half 2017 Results27.7.2017 17:00Pressemelding

Regulatory News: The interim consolidated financial statements for the six months ended 30 June 2017 were approved by the Board of Directors of Société Foncière Lyonnaise (Paris:FLY) on 27 July 2017, at a meeting chaired by Juan-Jose Brugera. First-half business indicators were robust, thanks to the high portfolio occupancy rate, while the period also saw gains in the portfolio's appraisal value and the Company's net asset value. The auditors have completed their review of the interim financial statements. Consolidated data (€ millions)                

Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA®27.7.2017 13:00Pressemelding

Boehringer Ingelheim announced today that the first patient has been enrolled into its VOLTAIRE-X interchangeability study. The goal of the study is to demonstrate that BI 695501 is interchangeable with the U.S.-marketed formulation of Humira®* 40mg/0.8mL. This is the first study in the U.S. to investigate an interchangeability designation for an adalimumab biosimilar candidate. The study will compare the pharmacokinetics and clinical outcomes between patients receiving Humira® continuously, versus those who switch repeatedly between Humira® and BI 695501, Boehringer Ingelheim’s adalimumab biosimilar candidate.1 The study will also assess safety, immunogenicity and efficacy.1 “We are pleased that the first patient has now been enrolled in VOLTAIRE-X, and look forward to continued recruitment and patient follow-up,” said Ivan Blanarik, Senior Vice President and Head of

Acxiom Launches Connected Spaces27.7.2017 12:30Pressemelding

Today, Acxiom® (Nasdaq: ACXM), in collaboration with Adobe, announced the launch of Connected Spaces, a global solution aimed at delivering more relevant omnichannel experiences to customers. Connected Spaces is designed to revolutionise customer experience and business returns for retail, travel and leisure locations such as airports, malls, sports stadiums, concert arenas and resorts. A pioneering example is Heathrow airport. Heathrow is able to deliver more relevant communications to customers in real-time as part of its overall engagement strategy and is already generating exceptional results including an increase in spend of 20-25 percent for engaged customers. Common to airports, malls and the like is a high footfall of consumers who intend to visit multiple concession, franchise, or subcontracted brands operating in their environments. This can translate to a relative

Watch BizWireTV: Helix Brings DNA Kits to the Public and Michael Kors Gets Ready to Buy Jimmy Choo27.7.2017 12:08Pressemelding

On the latest BizWireTV, catch the latest Quick Biz Hits. Also see what’s happening in the startup world with the Accelerator Report, featuring the VC Watch and this week’s Startup Standout. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170727005456/en/ BizWireTV is hosted by Jordyn Rolling (Photo: Business Wire) Now you can watch BizWireTV, and the latest breakthroughs in tech from the biggest brands, on any screen you want by downloading the new app through the Apple TV and iPhone App Store and Google Play for Android devices. Top of the Wire Helix launches first online consumer marketplace for DNA-powered products that offer insights on ancestry, entertainment, family, fitness, health and nutrition. Watch BizWireTV to

European Commission Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria27.7.2017 11:05Pressemelding

Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company dedicated to bringing first in class, specific, non-absorbed, oral enzyme therapeutics to patients with serious renal, urologic and orphan diseases, announced today that the European Commission has granted orphan drug designation to Allena’s investigational product ALLN-177, Bacillus subtilis oxalate decarboxylase, for the treatment of primary hyperoxaluria (PH). The orphan designation was granted to Allena Pharmaceuticals Ireland Limited, a subsidiary of Allena Pharmaceuticals, Inc. Allena’s lead compound ALLN-177, is being developed to treat patients with severe hyperoxaluria, a condition characterized by markedly elevated urinary oxalate excretion. PH, a type of severe hyperoxaluria, is a rare genetic disorder caused by endogenous overproduction of oxalate by the liver that can result in kidney stone disease, kidney

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom